|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
383,180,000 |
Market
Cap: |
3.22(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.255 - $9.15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
103,915 |
103,915 |
Total Buy Value |
$0 |
$0 |
$289,093 |
$289,093 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Adcock Richard |
CEO & President |
|
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,620 |
148,714 |
|
- |
|
California Capital Equity, Llc |
10% Owner |
|
2022-12-12 |
4 |
OE |
$5.67 |
$56,625,836 |
I/I |
9,986,920 |
9,986,920 |
|
- |
|
Adcock Richard |
CEO & President |
|
2022-02-05 |
4 |
D |
$5.39 |
$158,547 |
D/D |
(29,415) |
140,094 |
|
- |
|
Adcock Richard |
CEO & President |
|
2022-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,333 |
169,509 |
|
- |
|
Sachs David C. |
Chief Financial Officer |
|
2021-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,242 |
43,700 |
|
- |
|
Adcock Richard |
CEO & President |
|
2021-10-08 |
4 |
B |
$8.81 |
$16,995 |
I/I |
1,930 |
1,930 |
2.58 |
-16% |
|
Sachs David C. |
Chief Financial Officer |
|
2021-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,598 |
26,458 |
|
- |
|
Adcock Richard |
Chief Executive Officer |
|
2021-09-09 |
4 |
D |
$9.95 |
$42,516 |
D/D |
(4,273) |
86,176 |
|
- |
|
Adcock Richard |
Chief Executive Officer |
|
2021-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,620 |
90,449 |
|
- |
|
Cohen Cheryl |
Director |
|
2021-08-23 |
4 |
AS |
$10.12 |
$149,795 |
D/D |
(14,801) |
200,617 |
|
-31% |
|
Cohen Cheryl |
Director |
|
2021-08-20 |
4 |
AS |
$10.00 |
$99,808 |
D/D |
(9,976) |
215,418 |
|
-39% |
|
Cohen Cheryl |
Director |
|
2021-08-18 |
4 |
AS |
$10.03 |
$21,389 |
D/D |
(2,133) |
225,394 |
|
-34% |
|
Cohen Cheryl |
Director |
|
2021-08-17 |
4 |
AS |
$10.12 |
$439,361 |
D/D |
(43,398) |
227,527 |
|
-38% |
|
Simon Barry J. |
Director |
|
2021-05-25 |
4 |
S |
$16.18 |
$1,436,822 |
D/D |
(88,787) |
3,102,507 |
|
36% |
|
Simon Barry J. |
Director |
|
2021-05-24 |
4 |
S |
$16.02 |
$340,071 |
D/D |
(21,223) |
3,191,294 |
|
36% |
|
Simon Barry J. |
Director |
|
2021-05-21 |
4 |
S |
$16.09 |
$241,164 |
D/D |
(14,990) |
3,212,517 |
|
39% |
|
Simon Barry J. |
Director |
|
2021-05-05 |
4 |
OE |
$1.75 |
$99,943 |
D/D |
56,967 |
3,227,507 |
|
- |
|
Clark Wesley |
Director |
|
2021-03-09 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
Mp 13 Ventures, Llc |
Executive Chairman |
|
2021-03-09 |
4 |
A |
$0.00 |
$0 |
I/I |
237,489,573 |
7,976,159 |
|
- |
|
Mp 13 Ventures, Llc |
Executive Chairman |
|
2021-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,723,182 |
29,473,932 |
|
- |
|
Adcock Richard |
Chief Executive Officer |
|
2021-02-05 |
4 |
D |
$23.72 |
$1,617,016 |
D/D |
(68,171) |
81,829 |
|
- |
|
Adcock Richard |
Chief Executive Officer |
|
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
|
- |
|
Simon Barry J. |
See remarks |
|
2021-02-05 |
4 |
AS |
$23.09 |
$510,267 |
D/D |
(22,100) |
3,170,540 |
|
-41% |
|
Simon Barry J. |
See remarks |
|
2021-02-05 |
4 |
OE |
$2.00 |
$44,165 |
D/D |
22,100 |
3,192,640 |
|
- |
|
Simon Barry J. |
See remarks |
|
2021-02-02 |
4 |
AS |
$20.65 |
$1,694,803 |
D/D |
(82,070) |
3,170,540 |
|
-29% |
|
195 Records found
|
|
Page 2 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|